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Collapsing focal segmental glomerulosclerosis (cFSGS) is
characterized by hyperplasia of glomerular epithelial cells.
In a mouse model of FSGS and in a patient with recurrent
idiopathic FSGS, we identified the proliferating cells as
parietal epithelial cells (PECs). In the present study, we have
evaluated the origin of the proliferating cells in cFSGS
associated with human immunodeficiency virus (HIV) and
pamidronate. We performed a detailed study of glomerular
lesions in biopsies of two patients with HIV-associated
cFSGS and a nephrectomy specimen of a patient with
pamidronate-associated cFSGS. Glomeruli were studied by
serial sectioning using light and electron microscopy and
immunohistochemistry to determine the epithelial cell
phenotype. We used Synaptopodin, vascular endothelial
growth factor, and CD10 as podocyte markers, CK8 and PAX2
as PEC markers and Ki-67 as marker of cell proliferation. The
newly deposited extracellular matrix was characterized using
antiheparan sulfate single-chain antibodies. The proliferating
cells were negative for the podocyte markers, but stained
positive for the PEC markers and the cell proliferation marker
Ki-67. The proliferating PAX-2 and CK8 positive cells that
covered the capillary tuft were always in continuity with
PAX-2/CK8 positive cells lining Bowman’s capsule. The
matrix deposited by these proliferating cells stained
identically to Bowman’s capsule. Our study demonstrates
that PECs proliferate in HIV and pamidronate-associated
cFSGS. Our data do not support the concept of the
proliferating, dedifferentiated podocyte.
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Focal segmental glomerulosclerosis (FSGS) is one of the most
common patterns of glomerular injury.1 Recently, various
morphological variants have been described and a new
classification was proposed.2 The traditional forms of FSGS
now classified as perihilar and FSGS – not otherwise specified,
lack epithelial cell proliferation and are characterized by
mesangial sclerosis, obliteration of glomerular capillaries,
formation of adhesions between the glomerular tuft and
Bowman’s capsule, podocyte hypertrophy, hyalinosis, and
intracapillary foam cells. In contrast, epithelial cell prolifera-
tion is prominent in the other variants, in particular in
collapsing FSGS, defined by segmental or global collapse of
the glomerular tuft associated with epithelial cell hypertrophy
and hyperplasia.
In recent studies on the pathogenesis of FSGS, a central
role was assigned to the visceral epithelial cell, the so-called
podocyte. The podocyte is considered to be a highly
specialized and differentiated cell, unable to replicate. Kriz
et al.3–5 have studied the development of FSGS in various rat
model. Based on these studies, Kriz and Mundel (reviewed in
Mundel and Shankland6) proposed that podocyte loss
(podocytopenia) was the critical starting event in FSGS.
Neighboring podocytes cannot compensate for this loss,
resulting in denudation of the glomerular basement mem-
brane and formation of an adhesion between the capillary
tuft and the parietal epithelial cells (PECs).
The concept of the terminally differentiated, not-replicat-
ing podocyte seemed incompatible with the development of
the proliferative lesions observed in collapsing FSGS. Since
the proliferating cells cover the glomerular tuft they are
considered by several investigators to be of podocytic
origin,7,8 although they do not express podocyte markers
such as synaptopodin, vascular endothelial growth factor
(VEGF) and Wilm’s tumor antigen. These and similar
observations have fostered the concept that proliferating,
dedifferentiated podocytes are the main cell type involved in
the formation of cellular lesions in collapsing FSGS.9–11 Few
studies have questioned this concept, apparently because of
the localization of the cells, despite the observation that the
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proliferating cells express cytokeratins, a marker expressed by
PECs and not by podocytes.12–14
We previously studied the origin of the proliferating
epithelial cells in FSGS in more detail in the Thy-1.1
transgenic mouse (a model of collapsing FSGS), providing
evidence that in this model the proliferating epithelial cells
are of PEC origin.15 Recently, our conclusions were
confirmed and strengthened by Asano et al.,16 who found
PEC proliferation in their transgenic mouse with LacZ
expressing podocytes. Subsequently, we performed detailed
studies of glomerular lesions in a patient with recurrent
idiopathic FSGS.17 Using three-dimensional analysis we were
able to firmly establish that the proliferating cells were of PEC
origin.
Thus, our previous studies questioned a major contribu-
tion of proliferating podocytes to the formation of cellular
lesions in FSGS in general and we discussed the possibility
that in this respect human immunodeficiency virus (HIV)
associated collapsing FSGS (cFSGS) may be an exception.17
In the present study, we have investigated the characteristics
of the proliferating epithelial cells in glomerular lesions of
patients with HIV and pamidronate-associated FSGS. Our
study indicates that also in these conditions, most proliferat-
ing cells are PECs.
RESULTS
We studied biopsies from two HIV patients with collapsing
FSGS and a nephrectomy specimen from a patient with
pamidronate-associated collapsing FSGS. The latter patient
was treated with aminohydroxypropylidene bisphosphonate
(APD: ‘pamidronate’) because of persistent hypercalcaemia
after renal transplantation; she received oral APD in dayly
dosage of 300 mg for 20 months, 450 mg for 6 months and
600 mg for 2 months. Subsequently, intravenous (i.v.) APD
was administered in a dose of 60 mg at two-weekly intervals.
Severe proteinuria was noted after the third infusion.
The HIV biopsies contained 11 and 17 different glomeruli,
respectively, and the paraffin block from the nephrectomy
specimen contained over 77 glomeruli. The material was
serially sectioned and from each specimen more than 100
sections were examined. One of every five sections was
periodic acid Schiff stain stained for light microscopy (LM)
evaluation and intervening sections were retained for
immunostainings.
In the biopsies with HIV-associated nephropathy (HI-
VAN), we observed a wide spectrum of glomerular lesions by
LM. At the one end of the spectrum, there were normal
appearing glomeruli and at the other end glomeruli with
advanced sclerosis. For our analyses we focussed on glomeruli
with ‘early’ collapsing lesions, as defined by collapse of the
glomerular tuft without, or with only minimal, sclerosis
(deposition of new matrix). In these glomeruli, the collapsed
tuft was either still covered with a single layer of epithelial
cells with only limited segmental proliferation (two out of
28) or collapse was accompanied by a prominent increase of
epithelial cells, filling Bowman’s space (18 out of 28). These
epithelial cells appeared activated, with enlarged nuclei with
prominent nucleoli and vacuolation of the cytoplasm with
the presence of reabsorption droplets (Figure 1a). Some
glomeruli showed advanced sclerosis (seven out of 28) and
one glomerulus appeared normal. True adhesions of the tuft
to Bowman’s capsule were not found when analyzing serial
sections. Ultrastructural analysis by transmission electron
microscopy showed the presence of tubular reticular inclu-
sions in the glomerular endothelial cells of both HIV
biopsies. Podocytes appeared activated and showed foot
process effacement and microvillous transformation. The
podocytes in pamidronate nephropathy were enlarged and
highly vacuolated. The morpholocial appearance of collap-
sing lesions in pamidronate-associated cFSGS differed from
those in HIVAN, as in this condition we usually observed
only a single layer of epithelial cells in Bowman’s space,
covering the glomerular tuft (34 out of 77). In five of 77
glomeruli, we observed segmental multilayering of epithelial
cells in Bowman’s space. It was noted that these cells on top
of the tuft appeared severely injured with extreme vacuola-
tion and ballooning, more so than in HIVAN (Figure 1b).
Also, in pamidronate-associated cFSGS adhesions were not
found.
For phenotypic analysis of the epithelial cells in Bowman’s
space serial sections were stained with podocyte markers
(synaptopodin, CD10, and VEGF), PEC markers (CK8 and
paired cox protein 2 (PAX-2)) and proliferation marker Ki-
67. To characterize the extracellular matrix we stained with an
anti-heparan sulfate (HS) single-chain antibody that in
normal glomeruli predominantly stains Bowman’s capsule
and not the glomerular basement membrane (HS4E4) and
one that stains only the glomerular basement membrane
and the mesangial matrix (HS4C3) (markers are described
in Table 1). To strengthen our findings, we additionally
a b
Figure 1 | Glomerular histology in HIVAN and pamidronate
nephropathy. Glomerular histology (periodic acid Schiff stain
staining) in (a) HIV-associated cFSGS and (b) pamidronate-associated
cFSGS. (a) (HIVAN) shows a glomerulus with collapse of the capillary
tuft and prominent epithelial cell proliferation in Bowmans space.
Most of the glomeruli in our HIV biopsies had this appearance (18 out
of 28). The epithelial cells appeared activated, with enlarged nuclei
with prominent nucleoli and vacuolation of the cytoplasm with the
presence of reabsorption droplets. (b) Podocyte injury with
enlargement, vacuolation and ballooning was more evident in
pamidronate-associated cFSGS and multilayering of epithelial
cells in Bowman’s space was only sporadically and segmentally
observed (a, b  450).
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performed VEGF/CK8, Synaptopodin/CK8 and CD10/CK8
double stainings.
In normal control kidney tissue, the cells lining Bowman’s
capsule (PEC) uniformly stained for PAX-2 and were
negative (occasional weak positivity was observed) for CK8
(not shown). Podocytes uniformly stain for synaptopodin
and CD10. CD10/CALLA is not a podocyte specific marker
but in humans strongly stains podocytes in addition to brush
border and vascular smooth muscle cells.18 In HIVAN normal
looking glomeruli also demonstrated uniform PAX-2 staining
and additionally showed strong CK8 staining in a segmental
pattern, compatible with activation of PECs (Figure 2a). In
glomeruli with collapse and limited cell proliferation, CK8
positive cells segmentally covered the capillary tuft (Figure 2c
and d). These cells were always in contact with CK8-positive
cells lining Bowman’s capsule. The remainder of the tuft was
covered with a single layer of cells that were negative for all
PEC and podocyte markers except for CD10, which was
strongly and uniformly positive. In glomeruli with promi-
nent hypercellularity epithelial proliferation was confimed by
positive staining for Ki-67 (Figure 3b). Most cells in
Bowman’s space were CK8 and PAX 2 positive (Figure 3a).
In these glomeruli, there was often no or only faint
expression of synaptopodin (Figure 3c). Notably, most cells
in the periphery of the glomerular tuft were positive for
CD10 (Figure 3d), thus confirming that podocytes were still
present. To strengthen these findings, we additionally
performed Synaptopodin/CK8 (Figure 3e) and CD10/CK8
(Figure 3f) double stainings. No cells were found doubly
positive for synaptopodin/CD10 or CK8. In more advanced
lesions eventually the podocytes lost all there markers.
Also in pamidronate nephropathy we observed focal and
segmental CK8 expression in normal appearing glomeruli
(Figure 4a, left). In glomeruli, with collapse CK8 positive cells
were found overlying the capillary tuft (Figure 4a, right) and
occasionally continuity of CK8 positive cells covering the tuft
and CK8 positive cells covering Bowman’s capsule was seen
away from the vascular pole. VEGF expression is present in a
normal appearing glomerulus (Figure 4a, left) and is absent
in an affected glomerulus (Figure 4a, right). The expression
pattern observed in the normal appearing glomerulus is
identical to the expression observed in normal glomeruli in
Table 1 | Antibodies used for the detection of glomerular antigens
Antigen Primary antibody Dil. Supplier/reference
Podocyte components
Synaptopodin Mouse anti-synaptopodin 1 Progen, Heidelberg, Germany
CD10 Rabbit anti-human CD10 50 Monosan, Caltag lab., Burlinggame
VEGF ISH m-RNA Probe (*ng/ml) 100* 26
PEC components
PAX-2 Rabbit anti-human PAX-2 50 Zymed laboratories Inc. San Francisco, USA
Cytokeratin 8 Mouse anti-human CAM 5.2 (CK8) 50 BD Biosciences, San Diego, CA
Proliferation
Ki-67 Mouse anti-human MIB-1 200 Dako, Glostrup, Denmark
Bouwman’s capsule
Heparan sulfate single chain Single-chain antibody HS4E4 1 25
GBM
Heparan sulfate single chain Single-chain antibody HS4C3 1 24
GBM, glomerular basement membrane; PEC, parietal epithelial cell; VEGF, vascular endothelial growth factor.
*Concentration=Dil. 100 ng/ml.
CK8
CK8 HS4E4
a b
c d
PAS
Figure 2 | Phenotype of proliferating epithelial cells in
HIV-associated nephropathy in segmental lesions. (a) A section
of a normal looking glomerulus (no lesions) with segmental CK8
positive cells lining Bowman’s capsule. (b) The anti-HS single-chain
antibody HS4E4 showed that newly deposited matrix in areas of
epithelial proliferation stained as Bowman’s capsule, shown for a
glomerulus with more advanced sclerosis. (c and d) In glomeruli
with collapse, podocyte hypertrophy and limited cell proliferation,
CK8 positive cells segmentally covered the capillary tuft. These
cells were always in contact with CK8 positive cells lining
Bowman’s capsule, as demonstrated in serial sections (a–d  450).
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humans or mice (see Supplementary Figure S1). Ki-67
positivity was noted in PEC’s covering Bowman’s capsule
(Figure 4d). Segmentally CD10 positivity was observed
underneath CK8 positive cells (Figure 4b and c). Of note,
CK8 positive cells covering the tuft were interspersed with
CK8 negative CD10 positive cells, indicating the presence of
residual podocytes (Figure 4c, asterisk). This latter finding
was also confirmed by a Synaptopodin/CK8 (Figure 4e)
double staining. We never observed coexpression of CK8/
PAX2 with podocytemarkers!
In both HIV and Pamidronate-associated cFSGS staining
with the anti-HS single-chain antibody HS4E4 showed that
new matrix that stained as Bowman’s capsule was sometimes
deposited in areas of epithelial proliferation. More extensive
deposition of HS4E4 positive extracellular matrix was seen in
glomeruli with more advanced sclerosis (Figure 2b).
DISCUSSION
Our study demonstrates that most of the proliferating cells in
HIV and pamidronate-associated collapsing FSGS are PECs.
This conclusion is based on the finding that the proliferating
cells are often positive for CK8, always positive for the PEC
marker PAX2 and negative for the podocyte markers
synaptopodin, CD10, and VEGF. In addition, the staining
characteristics of the extracellular matrix that is produced by
the proliferating cells are identical to those of Bowman’s
capsule. Admittedly, the use of cellular markers to define the
origin of proliferating cells can be questioned, since it can be
CK8CD10
VEGF/CK8
Syn/CK8Ki-67
*
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Figure 4 | Phenotype of epithelial cells in pamidronate nephro-
pathy. We observed a focal and segmental CK8 expression by PECs
lining Bowmans capsule, in normal appearing glomeruli (a, left, red
staining). (a, right) In more advanced glomerular lesions, CK8 positive
cells were also found overlying the capillary tuft. VEGF expression is
(a, left, blue staining) present in podocytes of a normal appearing
glomerulus and (a, right) is absent in an affected glomerulus. In serial
sections, (b, arrow) segmental CD10 positivity was observed,
(b, arrowhead) underneath CK8 positive cells, indicating the presence
of some residual podocytes. Sometimes CK8 positive cells covering
the tuft were interspersed with CK8 negative but CD10 positive cells.
These CD10 positive cells showed already vacuolization and
ballooning (b, c, asterisk). This latter finding was also confirmed by a
Synaptopodin/CK8 double staining (e). We never observed VEGF/CK8
coexpression or Synaptopodin/CK8 coexpression. Epithelial cells
lining Bowman’s capsule and the glomerular tuft were mitotically
active (d) althought proliferation in HIVAN was more extensive
(a, d  450, b, c, e  900).
CD10Synaptopodin
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Figure 3 | Phenotype of proliferating epithelial cells in
HIV-associated nephropathy in glomeruli with extensive
proliferation. In (a–d) serial sections are shown. The proliferating
cells were mostly CK8 positive (e, f – red staining) and almost all
were PAX 2 positive (a). (b) Proliferation was confimed by Ki-67.
(c) Dedifferentiated podocytes lost expression of synaptopodin,
(d) but were still positive for CD10. Doublestainings
(e) Synaptopodin/CK8 and (f) CD10/CK8 confirmed that the
proliferating cells (asterisk) were positive for CK8 and are found
adjacent/on top of Synaptopodin or CD10 positive residual
podocytes. No cells were found doubly positive for Synaptopodin/
CD10 and CK8. In more advanced lesions, podocytes lost all there
markers. In (f) (arrow), a single podocyte has kept its expression
for CD10 (a–d  450, e, f  700).
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argued that cellular activation may induce phenotypic
changes and could cause a switch from an activated podocyte
phenotype to a parietal cel phenotype. However, the CK8 and
PAX-2 positivity strongly supports the PEC origin of these
cells as shown in our previous study.17 In normal kidney,
PECs are negative or stain only faintly positive for CK8. In
some of the normal appearing glomeruli in our patients, there
was strong CK8 staining of cells lining Bowman’s capsule in a
segmental distribution. By serial sectioning, we could show
that in these glomeruli adhesions between the glomerular tuft
and Bowman’s capsule were absent, thus providing a strong
argument that these PECs acquire the CK8 positive phenotype
upon activation, prior to proliferation. Perhaps, the most
striking argument for our conclusion is the demonstration of
CK8 positive cells on top of residual CD10 and even
Synaptopodin positive podocytes by double staining.
Our present findings in HIV and pamidronate-associated
cFSGS confirm and extend the conclusions of our previous
studies. In the Thy-1.1 transgenic mouse, a model of
collapsing FSGS, we observed that the proliferating epithelial
cells strongly express PEC markers. In addition, we noted
that the staining characteristics of the newly formed
extracellular matrix are identical to Bowman’s capsule
arguing that this matrix is produced by PECs.15 Double
staining for the podocytic transgene Thy-1.1 and the
proliferation marker Ki-67 proved that there is no prolifera-
tion of podocytes during the development of FSGS lesions.
Asano et al.16 confirmed these findings in a recent study.
These authors have generated a transgenic mouse with
podocytes that express LacZ. Injection of immunotoxin; anti-
TAC (FU)-PE38, an immunotoxin against the podocytic
CD25 antigen, into these Nphs1-Cre/ROSA26-loxP/NEP25
mice, causes podocyte injury characterized by vacuolar
degeneration eventually leading to glomerular sclerosis.
In this model proliferating epithelial cells accumulated
in Bowman’s space, as seen in cFSGS. These authors found
no evidence for proliferation or transdifferentiation of
podocyte-derived cells but did find proliferating PECs
migrating onto the visceral site.
A detailed study of FSGS lesions in the kidney of a patient
with recurrent idiopathic FSGS17 revealed that also in
humans the proliferating cells in collapsing lesions are PECs.
Although these studies firmly established a role for PECs
in the cellular lesion of cFSGS in mice as well as in a patient
with idiopathic FSGS, we questioned if similar events would
occur in HIV-associated cFSGS. HIV-associated cFSGS is the
prototypical example of cFSGS, characterized by a very high
proliferation rate. Proliferating cells are by some authors
considered to be dysregulated podocytes, but data from the
literature are conflicting. Evidence from in vitro studies
showed that incorporation of HIV-1 Nef induces prolifera-
tion of podocytes.19 However, in mice podocyte-specific
expression of HIV-1 Nef does cause podocytes to enter the
cell cycle, but does not lead to completion of mitosis.20
A recent study in a mouse model of HIV-nephropathy (the
HIV13FBV mouse) has provided additional support for our
conclusions.21 These mice express HIV-1 genes in podocytes
and avid cell proliferation is observed within Bowman’s
space. The extracapillary proliferating cells adjacent to the
PECs lining Bowman’s capsule were often positive for Ki-67
and cytokeratin, whereas the cells adjacent to the glomerular
basement membrane were rarely positive for Ki-67. No cells
were found doubly positive for synaptopodin and Ki-67. From
their observations the authors conclude that most proliferating
cells in Bowman’s space are derived from PECs.21
Barisoni et al.7 and Bariety et al.9 proposed that the loss of
specific podocyte markers defines a novel dysregulated and
proliferating podocyte phenotype and suggests a common
pathogenetic mechanism in collapsing FSGS. In our studies,
we found that in collapsing idiopathic FSGS and HIV-
associated nephropathy, there was disappearance of podocyte
markers, consistent with dedifferentiation. Synaptopodin
disappeared very early but remarkably CD10/CALLA22
remained positive longer, to disappear in advanced lesions.
Other investigators also observed a variable degree of
expression reduction for different podocyte markers, espe-
cially in unaffected portions of the tuft in segmentally injured
glomeruli, or in glomeruli without any visible collapse or
other histologic abnormalities.7 Our findings are therefore
consistent with dysregulation of podocytes but do not
support proliferation of podocytes.
To summarize our date, in HIV and pamidronate-
associated cFSGS, we do find dedifferentiation of podocytes
but most of the epithelial cells in Bowman’s space are derived
from the parietal epithelium. These findings are similar to
what we previously observed in a patient with recurrent
idiopathic FSGS in both the segmental collapsing lesions and
noncollapsing FSGS lesions with prominent epithelial
hyperplasia. Therefore, it can be argued that in all forms of
FSGS with prominent epithelial hyperplasia, there is
proliferation of PECs and that in this respect collapsing
FSGS can be included in the spectrum of FSGS and need not
be regarded as a distinct entity caused by a dysregulated
podocyte phenotype. It can be hypothesized that a common
pathogenetic mechanism applies to all variants of FSGS, and
that the type of lesion that is seen depends on the extent of
podocyte activation. In FSGS, secondary to hyperfiltration
(often perihilar variant), podocyte activation may be focal
and mere loss of podocytes with subsequent adherence of
PECs to the glomerular tuft results in sclerosis.5 If podocyte
activation is more widespread and acute, as we belief is the
case in primary (idiopathic) FSGS, PEC proliferation is more
prominent. Presumably, PEC proliferation is the direct result
of interactions between activated podocytes and PECs and
growth factors produced by podocytes may play an
important role. In HIV-associated collapsing FSGS promi-
nent epithelial proliferation follows massive podocyte
activation upon integration of the viral genome. In
pamidronate collapsing FSGS rapid widespread toxic loss of
podocytes may lead to the collapsing phenotype with less
PEC proliferation as compared to HIV-associated collapsing
FSGS.
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In conclusion, most of the proliferating cells in collapsing
glomerulopathy are derived from the parietal epithelium.
This conclusion holds for all forms of cFSGS, that is,
idiopathic, Pamidronate, and HIV-associated FSGS.
MATERIALS AND METHODS
Patients
We studied biopsies from two HIV patients with collapsing FSGS
and a nephrectomy specimen from a patient with pamidronate-
associated collapsing FSGS. The latter patient was treated with
aminohydroxypropylidene bisphosphonate (APD:‘pamidronate’)
because of persistent hypercalcaemia after renal transplantation,
she received oral APD in dayly dosage of 300 mg for 20 months,
450 mg for 6 months and 600 mg for 2 months. Subsequently,
i.v. APD was administered in a dose of 60 mg at two-weekly
intervals. Severe proteinuria was noted after the third infusion.
The HIV biopsies contained 11 and 17 different glomeruli,
respectively, and the paraffin block from the nephrectomy specimen
contained over 77 glomeruli. The material was serially sectioned and
from each specimen more than 100 sections were examined.
One of every five sections was periodic acid Schiff stain stained
for LM evaluation and intervening sections were retained for
immunostainings.
LM
For LM, kidney fragments were fixed in formaldehyde, dehydrated,
and embedded in paraplast (Amstelstad, Amsterdam The Nether-
lands). Two micrometer sections were stained with periodic acid
Schiff, and with silver methenamine.23
Immunohistochemistry
Immunohistochemical staining was performed on kidney sections
fixed in 4% buffered formaldehyde for 24 h and embedded in
paraffin. Four micrometer sections were incubated with monoclonal
antibodies (mAbs) and polyclonal antibodies directed at various
markers for podocytes, PECs, as detailed in Table 1. As secondary
antibody we used power vision Poly-HRP–anti-mouse/rabbit/rat
immunoglobulin (IgG) (Immunologic, Klinipath, Duiven, The
Netherlands). Detection was carried out with the use of peroxidase
as label and diaminobenzidine as substrate.
For the doublestaining CD10/CK8, first the polyclonal antibody
CD10 was detected and completed. As detecting antibody we used
Envision AF-anti Rabbit IgG (Immunologic, Klinipath, Duiven, The
Netherlands), detection was carried out with the use of alkaline
phosphatase as label and FastBlue as substrate. Thereafter samples
were incubated with the mAb CK8, as detecting antibody we used
powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG (Immunologic,
Klinipath, Duiven, The Netherlands). Detection was carried out
with the use of peroxidase as label and 3-amino-9-ethyl-carbazole/
red as substrate.
For the doublestaining Synaptopodin/CK8, first the mAb
Synaptopodin was incubated and as detecting antibody we used
powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG (Immunologic,
Klinipath, Duiven, The Netherlands). Detection was carried out
with the use of peroxidase as label and diaminobenzidine as
substrate. Thereafter samples were incubated with the mAb CK8, as
detecting antibody we used powervision Poly-AP-anti-Mouse IgG
(Immunologic, Klinipath, Duiven, The Netherlands). Detection
was carried out with the use of alkaline phosphatase as label and
3-amino-9-ethyl-carbazole/red as substrate.
Immunofluorescence microscopy
Kidney fragments were snap-frozen in liquid nitrogen, and 2 mm
acetone fixed cryostat sections were used. Kidney sections were
incubated with antibodies directed against heparan sulfate species
(Table 1). The single-chain antibodies used for staining of heparan
sulfate species24,25 were detected via a rabbit antibody directed
against the VSV-g epitope tag (ICL, Oregon, USA) and finally
detected with a goat anti-rabbit AlexaTM 488 antibody (Molecular
probes Inc, Leiden, The Netherlands). The sections were examined
with a fluorescence microscope (Leica microsystems GmbH,
Heidelberg, Germany).
In situ hybridization
Kidney sections were fixed in 4% buffered formaldehyde for 24 h
and embedded in paraffin. Four micrometer sections were incubated
and subjected to VEGF in situ hybridization using a digoxigenin-
labeled VEGF-A antisense RNA probe,26 as secondary antibody we
used sheep anti-digoxigenin alkaline phosphatase. Detection was
carried out with nitro-blue tetrazolium chloride/5-bromo-4-chloro-
3-nido-lyphosphate p-tolsaff, the corresponding sense probe was
used as a control. This in situ hybridization was followed by
immunohistochemical staining with the mAb CK8. As secondary
antibody we used biotin-labeled rabbit anti-mouse (Immunologic,
Klinipath, Duiven, The Netherlands). Detection was carried out
with the use of ABC Vectastain, peroxidase as label and 3-amino-9-
ethyl-carbazole/red as substrate.
Transmission electron microscopy
For electron microscopy, we used immersion fixation, small
fragments of cortex were fixed in 2.5% glutaraldehyde dissolved in
0.1 M sodium cacodylate buffer, pH 7.4, overnight at 41C and washed
in the same buffer. The tissue fragments were postfixed in palade-
buffered 2% OsO4 for 1 h, dehydrated, and embedded in Epon812,
Luft’s procedure (Merck, Darmstadt, Germany). Ultrathin sections
were contrasted with 4% uranyl acetate for 45 min and subsequently
with lead citrate for 5 min at room temperature. Sections were
examined in a Jeol 1200 EX2 electron microscope (JEOL, Tokyo,
Japan).
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